Pliant

Pliant is a California-based biotechnology company that researches and develops novel therapeutics for the treatment of fibrosis.

Business Model:

Revenue: $9.7M

Employees: 51-200

Detailed Pliant Information

Geographic Data

Pliant headquarters map

Address: 260 Littlefield Avenue

City: South San Francisco

State: CA

Zip: 94080

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$200M

Raised Total:

$407M

Metrics

3,108,430Website Global Rank

5,361Website Monthly Traffic

Twitter Followers

Description

Pliant is a California-based biotechnology company that researches and develops novel therapeutics for the treatment of fibrosis.

Contact Phone:
+16504816770

Contact Email:

Pliant went public on 6/2/2020 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
6/2/2020

IPO Valuation:
$547M

Ticker Symbol:
PLRX

IPO Price:
$16/share

Amount Raised:
$144M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
7/2022 Post-IPO Equity $230M
7/2022 Post-IPO Equity $200M
7/2018 Series B $0 Cowen Healthcare Investments
Agent Capital
Eventide
Menlo Ventures
S-Cubed Capital
Schroder Adveq
Cowen Healthcare Investments
Agent Capital
Eventide
Menlo Ventures
S-Cubed Capital
Schroder Adveq
5/2022 Post-IPO Debt $100M Oxford Finance LLC
2/2016 Series A $0 Third Rock Ventures
pH Pharma
Third Rock Ventures
pH Pharma
3/2020 Series C $0 Novartis Institutes for Biomedical Research
Agent Capital
Cormorant Asset Management
Logos Capital
Eventide
Schroder Adveq
S-Cubed Capital
Cowen Healthcare Investments
Redmile Group
Menlo Ventures
Novartis Institutes for Biomedical Research
Farallon Capital Management
Surveyor Capital
Novartis Institutes for Biomedical Research
Agent Capital
Cormorant Asset Management
Logos Capital
Eventide
Schroder Adveq
S-Cubed Capital
Cowen Healthcare Investments
Redmile Group
Menlo Ventures
Novartis Institutes for Biomedical Research
Farallon Capital Management
Surveyor Capital
1/2023 Post-IPO Equity $287.5M
1/2023 Post-IPO Equity $287.5M
6/2020 IPO $230M

12/2019 Series C $100M Novartis
Redmile Group
Farallon Capital Management
Surveyor Capital
Logos Capital
Eventide Asset Management
Cowen Healthcare Investments
Schroder Adveq
Menlo Ventures
SCubed Capital
Agent Capital
Novartis
Redmile Group
Farallon Capital Management
Surveyor Capital
Logos Capital
Eventide Asset Management
Cowen Healthcare Investments
Schroder Adveq
Menlo Ventures
SCubed Capital
Agent Capital
3/2020 Series C 12 $100.4M Novartis Institutes for Biomedical Research
Agent Capital
Cormorant Asset Management
Logos Capital
Eventide
Schroder Adveq
S-Cubed Capital
Cowen Healthcare Investments
Redmile Group
Menlo Ventures
Novartis Institutes for Biomedical Research
Novartis Institutes for Biomedical Research
Agent Capital
Cormorant Asset Management
Logos Capital
Eventide
Schroder Adveq
S-Cubed Capital
Cowen Healthcare Investments
Redmile Group
Menlo Ventures
Novartis Institutes for Biomedical Research
7/2018 Series B 6 $62M Cowen Healthcare Investments
Cowen Healthcare Investments
2/2016 Series A 2 $45M Third Rock Ventures
Third Rock Ventures
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research